BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25777142)

  • 21. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.
    Huang N; Cheng S; Mi X; Tian Q; Huang Q; Wang F; Xu Z; Xie Z; Chen J; Cheng Y
    Mol Carcinog; 2016 Nov; 55(11):1613-1626. PubMed ID: 26455908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sevoflurane downregulates insulin-like growth factor-1 to inhibit cell proliferation, invasion and trigger apoptosis in glioma through the PI3K/AKT signaling pathway.
    Gao C; He XF; Xu QR; Xu YJ; Shen J
    Anticancer Drugs; 2019 Aug; 30(7):e0744. PubMed ID: 31305291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.
    Sun J; Zhang D; Bae DH; Sahni S; Jansson P; Zheng Y; Zhao Q; Yue F; Zheng M; Kovacevic Z; Richardson DR
    Carcinogenesis; 2013 Sep; 34(9):1943-54. PubMed ID: 23671130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
    Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.
    Peng R; Jiang B; Ma J; Ma Z; Wan X; Liu H; Chen Z; Cheng Q; Chen R
    Oncol Rep; 2013 Nov; 30(5):2195-202. PubMed ID: 24008630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
    Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
    Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 35. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.
    Dai B; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2016 Jul; 36(1):173-80. PubMed ID: 27176716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
    Zhong G; Li H; Shan T; Zhang N
    Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of small nucleolar RNA SNORD44 on the proliferation, apoptosis and invasion of glioma cells.
    Xia XR; Li WC; Yu ZT; Li J; Peng CY; Jin L; Yuan GL
    Histochem Cell Biol; 2020 Apr; 153(4):257-269. PubMed ID: 32062699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.